GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India flag India · Delayed Price · Currency is INR
2,504.40
+18.40 (0.74%)
At close: Mar 12, 2026

NSE:GLAXO Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
424,218487,432329,173224,319281,714244,012
Market Cap Growth
-0.24%48.08%46.74%-20.37%15.45%15.67%
Enterprise Value
403,966466,472313,334211,499270,099237,483
Last Close Price
2504.402843.281889.181257.081489.751263.15
PE Ratio
41.5552.5555.8036.7316.6268.13
PS Ratio
11.1613.009.536.908.598.34
PB Ratio
24.8424.9818.5212.8810.5816.51
P/TBV Ratio
24.9625.1518.7713.1410.7217.01
P/FCF Ratio
-38.4859.7650.9636.3045.72
P/OCF Ratio
-37.7956.5646.3334.7542.22
EV/Sales Ratio
10.6312.449.076.508.248.12
EV/EBITDA Ratio
31.5240.4735.5826.8336.3641.42
EV/EBIT Ratio
32.9241.8637.3528.2638.6545.71
EV/FCF Ratio
-36.8256.8948.0534.8044.50
Debt / Equity Ratio
0.020.010.010.010.010.02
Debt / EBITDA Ratio
0.030.010.020.020.030.06
Debt / FCF Ratio
-0.010.030.040.030.07
Net Debt / Equity Ratio
-1.19-1.27-1.03-0.94-1.06-0.75
Net Debt / EBITDA Ratio
-1.60-2.16-2.09-2.08-3.78-1.92
Net Debt / FCF Ratio
--1.96-3.34-3.72-3.62-2.07
Asset Turnover
-0.981.000.820.850.94
Inventory Turnover
-2.812.752.622.552.49
Quick Ratio
-1.501.451.501.831.02
Current Ratio
-1.791.841.882.181.63
Return on Equity (ROE)
-49.75%33.53%27.59%18.39%17.42%
Return on Assets (ROA)
-18.17%15.24%11.75%11.28%10.39%
Return on Invested Capital (ROIC)
--2875.95%-299.81%55.90%
Return on Capital Employed (ROCE)
-50.60%41.30%37.40%23.80%29.50%
Earnings Yield
2.41%1.90%1.79%2.72%6.02%1.47%
FCF Yield
-2.60%1.67%1.96%2.76%2.19%
Dividend Yield
1.69%1.48%1.69%2.55%2.01%2.38%
Payout Ratio
-80.79%91.80%249.80%29.89%189.04%
Total Shareholder Return
1.69%1.48%1.69%2.55%2.01%2.38%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.